Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
79.10
0.00 (0.00%)
Apr 2, 2025, 1:30 PM CST

Foresee Pharmaceuticals Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
418.69195.04301.51226.03230.44
Upgrade
Revenue Growth (YoY)
114.67%-35.31%33.39%-1.91%206.44%
Upgrade
Cost of Revenue
178.8981.0725.5450.9557.01
Upgrade
Gross Profit
239.8113.97275.97175.08173.43
Upgrade
Selling, General & Admin
147.32160.16124.2399.07120.58
Upgrade
Research & Development
1,172961.44621.18614.64537.65
Upgrade
Operating Expenses
1,3201,122745.41713.71658.23
Upgrade
Operating Income
-1,080-1,008-469.44-538.63-484.79
Upgrade
Interest Expense
-6.71-2.85-0.4-0.68-1
Upgrade
Interest & Investment Income
28.2823.538.343.531.04
Upgrade
Currency Exchange Gain (Loss)
--2.3223.35-3.051.37
Upgrade
Other Non Operating Income (Expenses)
25.010.831.210.170.1
Upgrade
EBT Excluding Unusual Items
-1,033-988.45-436.96-528.66-483.28
Upgrade
Gain (Loss) on Sale of Investments
--0.290.80.52
Upgrade
Gain (Loss) on Sale of Assets
--0.2-0.31-0.13-0.06
Upgrade
Asset Writedown
---1.16--
Upgrade
Other Unusual Items
-0.01---
Upgrade
Pretax Income
-1,033-988.64-438.13-527.99-482.81
Upgrade
Income Tax Expense
47.8747.6734.5141.2827.9
Upgrade
Net Income
-1,081-1,036-472.64-569.27-510.71
Upgrade
Net Income to Common
-1,081-1,036-472.64-569.27-510.71
Upgrade
Shares Outstanding (Basic)
137127118117101
Upgrade
Shares Outstanding (Diluted)
137127118117101
Upgrade
Shares Change (YoY)
7.93%7.82%0.57%15.74%5.71%
Upgrade
EPS (Basic)
-7.87-8.14-4.00-4.85-5.04
Upgrade
EPS (Diluted)
-7.87-8.14-4.00-4.85-5.04
Upgrade
Free Cash Flow
-1,323-933.84-291.29-220.19-687.58
Upgrade
Free Cash Flow Per Share
-9.63-7.34-2.47-1.88-6.78
Upgrade
Gross Margin
57.27%58.44%91.53%77.46%75.26%
Upgrade
Operating Margin
-257.90%-516.63%-155.70%-238.30%-210.38%
Upgrade
Profit Margin
-258.20%-531.33%-156.76%-251.86%-221.63%
Upgrade
Free Cash Flow Margin
-316.07%-478.80%-96.61%-97.42%-298.38%
Upgrade
EBITDA
-999.27-950.68-429.72-498.38-446.65
Upgrade
EBITDA Margin
-238.67%--142.52%-220.50%-193.82%
Upgrade
D&A For EBITDA
80.5256.9539.7240.2438.14
Upgrade
EBIT
-1,080-1,008-469.44-538.63-484.79
Upgrade
EBIT Margin
-257.90%--155.70%-238.30%-210.38%
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.